FPH.NZ
Latest Trade
31.64NZDChange
-0.64(-1.98%)Volume
413,143Today's Range
-
32.7552 Week Range
-
37.89As of on the New Zealand Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 32.28 |
|---|---|
Open | 32.35 |
Volume | 413,143 |
3M AVG Volume | 17.96 |
Today's High | 32.75 |
Today's Low | 31.64 |
52 Week High | 37.89 |
52 Week Low | 21.10 |
Shares Out (MIL) | 576.12 |
Market Cap (MIL) | 18,234.93 |
Forward P/E | 41.98 |
Dividend (Yield %) | 1.00 |
Fisher & Paykel Healthcare Corporation Posts HY Net Profit After Tax Of $225.5 Mln, Up 86%
Fisher & Paykel Healthcare Says Commenced Planning For 3rd Manufacturing Facility In Mexico
Fisher & Paykel Healthcare Sees FY21 Operating Revenue Of About NZ$1.61 Bln
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.
Industry
Medical Equipment & Supplies
Contact Info
15 Maurice Paykel Place, East Tamaki
1061
New Zealand
+64.9.5740100
https://www.fphcare.com/Executive Leadership
Antony John Carter
Non-Executive Independent Chairman of the Board
Lewis George Gradon
Chief Executive Officer, Managing Director, Director
Lyndal Jane York
Chief Financial Officer
Paul Nigel Shearer
Senior Vice President - Sales and Marketing
Debra Lumsden
Vice President of Human Resources Officer
Price To Earnings (TTM) | 46.82 |
|---|---|
Price To Sales (TTM) | 11.38 |
Price To Book (MRQ) | 14.90 |
Price To Cash Flow (TTM) | 39.57 |
Total Debt To Equity (MRQ) | 8.98 |
LT Debt To Equity (MRQ) | 3.27 |
Return on Investment (TTM) | 33.31 |
Return on Equity (TTM) | 27.13 |
Fisher & Paykel Healthcare Corporation Ltd:
Fisher & Paykel Healthcare Corporation Ltd:
Fisher & Paykel Healthcare Corporation Ltd:
Fisher & Paykel Healthcare Corporation Ltd:
Fisher & Paykel Healthcare Corporation Ltd:
New Zealand medical device maker Fisher & Paykel Healthcare Corp Ltd and U.S. rival ResMed Inc have agreed to settle patent infringement disputes, ending a three-year tussle that spanned the globe and cost each side millions of dollars in legal fees.
Medical device maker Fisher & Paykel Healthcare and U.S.-based ResMed on Thursday agreed to settle disputes over patent infringement, bringing to an end a tussle spanning the globe.
Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea devices.
Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint in the United States against ResMed .
New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.
New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.
New Zealand medical device firm Fisher & Paykel Healthcare on Thursday raised its full-year profit guidance by more than two percent as it benefited from a weakening in the New Zealand dollar.
Fisher & Paykel Healthcare Corporation Ltd:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.